Index Overview
Nifty Pharma
Return Overview
1M
-6.71%
3M
-1.26%
6M
+10.19%
1Y
+12.67%
3Y
+19.32%
5Y
+12.67%
10Y
+8.22%
Max
+8.23%
Fundamentals
| Asset Type | Equity |
| Index Type | Sectoral Index |
| No. of Companies | 20 Companies |
| Market Cap Focus | Multi / Flexi Cap |
| Std Deviation (1 yr) | 0.86% |
| P/E | 52.48 |
| P/B | 8.07 |
| Div Yield | 0.57% |
| Asset Type | Equity |
| Index Type | Sectoral Index |
| No. of Companies | 20 |
| Market Cap Focus | Multi / Flexi Cap |
| P/E | 52.48 |
| P/B | 8.07 |
| Div Yield | 0.57% |
| Std Deviation (1 yr) | 0.86% |
Exchange Traded Funds (ETFs)
| Fund Name | ||||||||
|---|---|---|---|---|---|---|---|---|
| 25.89 | 1,736 | 0.18% | 0.02% | 12 | 0.01% | 0.21% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | 1M ADTO (Cr) | 1M Avg NAV Gap | All-In-Cost | Score |
|---|---|---|---|---|---|---|---|---|
| 25.89 | 1,736 | 0.18% | 0.02% | 12 | 0.01% | 0.21% |
Index Funds
| Fund Name | ||||||
|---|---|---|---|---|---|---|
| N/A | 163 | 0.32% | 0.06% | 0.38% |
Swipe to view more data →
| Fund Name | Last Close | AUM (Cr) | Avg Exp Ratio | Tracking Error | All-In-Cost | Score |
|---|---|---|---|---|---|---|
| N/A | 163 | 0.32% | 0.06% | 0.38% |
Sectoral Allocation
Total
100%
allocation
- Healthcare100.0%
- Healthcare100.0%
Index Constituents
| Name | Weight |
|---|
| Sun Pharmaceutical Industries Ltd. | 19.5% |
| Divi's Laboratories Ltd. | 12.0% |
| Laurus Labs Ltd. | 7.8% |
| Cipla Ltd. | 7.7% |
| Dr. Reddy's Laboratories Ltd. | 7.6% |
| Torrent Pharmaceuticals Ltd. | 7.2% |
| Lupin Ltd. | 5.0% |
| Aurobindo Pharma Ltd. | 4.7% |
| Glenmark Pharmaceuticals Ltd. | 3.6% |
| Alkem Laboratories Ltd. | 3.2% |
| Zydus Lifesciences Ltd. | 2.9% |
| Mankind Pharma Ltd. | 2.9% |
| Ipca Laboratories Ltd. | 2.7% |
| Biocon Ltd. | 2.6% |
| Gland Pharma Ltd. | 2.3% |
| Sai Life Sciences Ltd. | 2.1% |
| Wockhardt Ltd. | 1.8% |
| Ajanta Pharma Ltd. | 1.7% |
| Abbott India Ltd. | 1.4% |
| Piramal Pharma Ltd. | 1.3% |
NameWeight
Sun Pharmaceutical Industries Ltd.19.5%
Divi's Laboratories Ltd.12.0%
Laurus Labs Ltd.7.8%
Cipla Ltd.7.7%
Dr. Reddy's Laboratories Ltd.7.6%
Torrent Pharmaceuticals Ltd.7.2%
Lupin Ltd.5.0%
Aurobindo Pharma Ltd.4.7%
Glenmark Pharmaceuticals Ltd.3.6%
Alkem Laboratories Ltd.3.2%
Zydus Lifesciences Ltd.2.9%
Mankind Pharma Ltd.2.9%
Ipca Laboratories Ltd.2.7%
Biocon Ltd.2.6%
Gland Pharma Ltd.2.3%
Sai Life Sciences Ltd.2.1%
Wockhardt Ltd.1.8%
Ajanta Pharma Ltd.1.7%
Abbott India Ltd.1.4%
Piramal Pharma Ltd.1.3%
Holdings Concentration
Total covered: 100%
Top 1–5
5 holdings
54.6%
55%
share
Top 6–10
5 holdings
23.6%
24%
share
Top 11–20
10 holdings
21.8%
22%
share
Market Cap Classification
Total
100%
allocation
- Large Cap46.3%
- Mid Cap46.1%
- Small Cap7.5%
- Large Cap46.3%
- Mid Cap46.1%
- Small Cap7.5%
Index Methodology
| Factor Basis | Sector/Theme |
| What universe selected from? | Nifty 500 |
| Weightage? | Free-Float Market Cap Weighting; Max Weight per stock = 33% |
| Stocks Included | Max 20 stocks. Top 20 stocks from the Indian Pharma & Biotech sector are selected. |
| Exclusions | Constituents moving out of the Nifty 500 and currently part of the Nifty Pharma Index are excluded; |
| Factor Basis | Sector/Theme |
| Universe | Nifty 500 |
| Weightage | Free-Float Market Cap Weighting; Max Weight per stock = 33% |
| Stocks Included | Max 20 stocks. Top 20 stocks from the Indian Pharma & Biotech sector are selected. |
| Exclusions | Constituents moving out of the Nifty 500 and currently part of the Nifty Pharma Index are excluded; |
Index • Last updated: 26/10/2026
Note: Above data is based on average of ETFs / Index Funds.